Alphatec expects hit to U.S. spine business in Q3, shares fall

Alphatec Holdings

28/09/2021 15:28

** Shares of medical device company Alphatec Holdings Inc
 ATEC.O  down 3.7% at $13.16
    ** Expects Q3 revenue from its U.S. spinal device business
to be down sequentially, from Q2 2021  urn:newsml:reuters.com:*:nBw84x4Yba
    ** Says surgical procedure volumes have been
lower-than-expected due to resurgence of COVID-19 cases in the
United States
    ** However, co says it expects U.S. spine revenue to grow
over 25% year-over-year in Q3, citing factors such as strength
of adoption of its devices by surgeons
    ** Including session's moves, stock down 9.4% YTD

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))